SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-14-001105
Filing Date
2014-02-20
Accepted
2014-02-20 17:27:18
Documents
3
Period of Report
2014-02-18
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2218421z8-k.htm 8-K 44363
2 EX-3.1 a2218421zex-3_1.htm EX-3.1 42169
3 EX-3.2 a2218421zex-3_2.htm EX-3.2 195727
  Complete submission text file 0001047469-14-001105.txt   283510
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 14630736
SIC: 2834 Pharmaceutical Preparations